Inhaled Therapies, Azithromycin andMycobacterium Abscessusin Cystic Fibrosis Patients

European Respiratory Journal- United Kingdom

doi 10.1183/09031936.00065612

Full Text

Abstract

Available in

Date

Authors

Publisher

European Respiratory Society (ERS)

Related search

Daily Versus Weekly Azithromycin in Cystic Fibrosis Patients

Yearbook of Pulmonary Disease
2009English

Absolute Bioavailability and Intracellular Pharmacokinetics of Azithromycin in Patients With Cystic Fibrosis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2005English

Long-Term Inhaled Dry Powder Mannitol in Cystic Fibrosis

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2012English

Inhaled Aztreonam Lysine for Chronic AirwayPseudomonas Aeruginosain Cystic Fibrosis

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2008English

Inhaled Hypertonic Saline Reduces Pulmonary Exacerbations in Cystic Fibrosis

Thorax
PulmonaryRespiratory Medicine
2006English

Novel Antiviral Properties of Azithromycin in Cystic Fibrosis Airway Epithelial Cells

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2014English

Maintenance of Nutritional Status in Patients With Cystic Fibrosis: New and Emerging Therapies

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2012English

A Controlled Trial of Long-Term Inhaled Hypertonic Saline in Patients With Cystic Fibrosis

Survey of Anesthesiology
2007English

Optimising Inhaled Mannitol for Cystic Fibrosis in an Adult Population

Breathe
PulmonaryRespiratory Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy